Boston Financial & Equity closed its first deal of 2017.  Their newest lessee is a startup company, based in San Diego, CA and was referred to the company by a “venture” bank that couldn’t do the transaction.

The company was founded in 2013 and has been in R&D, developing a an enzymatic DNA technology. In 2016 they raised a seed round of $2.3 million, and at year end had a cash position left of $500,000. The need for $165,000 of critical need lab equipment, combined with the seed round investment, and an addition of a seasoned CEO, was an opportunity for BFEC to begin a strong relationship with a potentially well-funded biotech company.